Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders

Saturday, August 23, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

CHICAGO, Aug. 22 Allscripts HealthcareSolutions, Inc. ("Allscripts"), the leading provider of clinical software,connectivity and information solutions that physicians use to improvehealthcare, announced today that it filed a definitive proxy statement withthe U.S. Securities and Exchange Commission on Thursday, August 21, 2008 inrespect of the proposed transactions involving Allscripts, Misys plc ("Misys")and Misys Healthcare Systems LLC ("MHS"), a wholly owned subsidiary of Misys,as announced on March 18, 2008. Allscripts further announced that it willhold its annual meeting of stockholders on Monday, September 22, 2008, at10:00 a.m. Central Time, to approve certain actions required to be taken byAllscripts in connection with the proposed transactions, among other matters.The meeting will be held at One South Dearborn Street, Chicago, Ill. For moreinformation, please see the definitive proxy statement.


The Allscripts board of directors has approved the merger agreement withMisys and recommends approval of the share issuance and related transactionscontemplated by the merger agreement by Allscripts stockholders. Completionof the transaction is subject to certain conditions, including approvals bythe stockholders of Allscripts and the shareholders of Misys and othercustomary closing conditions. Subject to the satisfaction of these closingconditions, the transactions are expected to be completed on or aboutSeptember 26, 2008.

About Allscripts

Allscripts (Nasdaq: MDRX) is the leading provider of clinical software,connectivity and information solutions that physicians use to improvehealthcare. The company's unique solutions inform, connect and transformhealthcare, delivering improved care at lower cost. More than 40,000physicians and thousands of other healthcare professionals in clinics,hospitals and extended care facilities nationwide utilize Allscripts toautomate everyday tasks such as writing prescriptions, documenting patientcare, managing billing and scheduling, and safely discharging patients, aswell as to connect with key information and stakeholders in the healthcaresystem. To learn more, visit

Additional Information and Where to Find It

This communication is being made in respect of the proposed businesscombination involving a subsidiary of Allscripts and MHS, a wholly ownedsubsidiary of Misys. In connection with this proposed transaction, Allscriptshas filed with the Securities and Exchange Commission (the "SEC") a definitiveproxy statement. On August 22, 2008, Allscripts is mailing the definitiveproxy statement and proxy card to its stockholders of record as of August 15,2008. BEFORE MAKING ANY DECISION WITH RESPECT TO THE PROPOSED TRANSACTION,INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE PROXY STATEMENT AND OTHERRELEVANT MATERIALS WHEN THEY BECOME AVAILABLE, BECAUSE THEY WILL CONTAINIMPORTANT INFORMATION ABOUT THE COMPANY AND THE PROPOSED TRANSACTION.Investors and security holders can obtain copies of Allscripts' materials (andall other offer documents filed with the SEC) when available, at no charge onthe SEC's website: Copies can also be obtained at nocharge by directing a request for such materials to Allscripts at 222Merchandise Mart Plaza, Suite 2024, Chicago, Illinois 60654, Attention: LeeShapiro, Secretary. Investors and security holders may also read and copy anyreports, statements and other information filed by Allscripts with the SEC, atthe SEC public reference room at 100 F Street, N.E., Washington, D.C. 20549.Please call the SEC at 1-800-SEC-0330 or visit the SEC's website for furtherinformation on its public reference room. Allscripts' directors, executiveofficers and other members of management and employees may, under the rules ofthe SEC, be deemed to be participa

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store